| P2093 | author name string | Christopher D Payne | |
| | Diane L Phillips | |
| | Rebecca E Wrishko | |
| | Malcolm I Mitchell | |
| | S Thomas Forgue | |
| | Alun W Bedding | |
| | Beverley E Patterson | |
| P2860 | cites work | Chronopharmacokinetics: implications for drug treatment | Q33742389 |
| | Erectile dysfunction | Q33942524 |
| | Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality | Q34117094 |
| | Tadalafil | Q35537837 |
| | Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists | Q35586230 |
| | Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function | Q36457086 |
| | On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction | Q43583270 |
| | Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses | Q44156884 |
| | Effects of tadalafil on erectile dysfunction in men with diabetes | Q44231032 |
| | Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial | Q44499100 |
| | The efficacy and safety of tadalafil: an update | Q44923967 |
| | Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo | Q45215069 |
| | Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study | Q46901181 |
| | Confidence interval criteria for assessment of dose proportionality. | Q52069368 |
| | The log transformation is special | Q71982985 |
| | Chronopharmacokinetics. Current status | Q77306648 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 280-288 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Tadalafil pharmacokinetics in healthy subjects | |
| P478 | volume | 61 | |